Born in 1963 in Rheine Germany.
- Ph.D. in Biochemistry.
- 1989 - 1993:
- Research Associate at the Institute of Biochemistry in Münster.
- 1993 - 1993:
- BASF Lacquer & Colours Inc., Coil Coating Test laboratory, Chemical and Physical Analytics and Characterisation of Paints and Varnish.
- 1993 - 1997:
- Postdoctoral Fellow at the National Institute of Materials and Chemical Research (Ministry of International Trade and Industry, MITI), in Tsukuba, Japan.
- 1997 - 2000:
- Establishment of the Asia-Europe Trading & Consulting for various clients from the medical-biotechnology area.
- 2000 - 2003:
- Head of R&D, Production and QA at Easyway AG, Mohnheim, Germany.
- 2003 - 2004:
- Vice President of Sangui AG und Responsible for Business Development.
- 2005 - 2010:
- Area Manager for the Asia - Pacific Region, BRAHMS AG (part of Thermofisher Scientific).
- 2010 – present:
- Foundation of DMB-Consult and DMB-Diagnostics GmbH, Medical Sales & Marketing for Asia and Europe.
- 1994 - 1997:
- President of the Gaijin-Sumo-Society, Tsukuba, Japan.
- 1995 - 1997:
- Board Member of the European Researcher Association (SDSK) in Tokyo, Japan.
- Since 2003:
- Member of the German-Japanese Industrial Cooperation Committee (DJW).
- Since 2006:
- Member of the Committee of External Economic Relations of the IHK in Potsdam, Germany.
- Reorganisation; responsible for sales and financial planning; Contracting authority, the certification of Sangui according to DIN EN ISO 9001: 2000 and DIN EN ISO 13485: 2003 (CE marking);
- Sale of devices for diagnostic analysis and diagnostic markers (PCT, prenatal screening, heart, thyroid and tumour markers);
- Advisory role in setting up the distribution network of LifeCodexx AG.
- Development of a distribution network for cancer diagnostics.
- Development of sepsis diagnostics with sales development worldwide.
- Kamhieh-Milz J, Moftah RF, Bal G, Futschik M, Sterzer V, Khorramshahi O, Burow M, Thiel G, Stuke-Sontheimer A, Chaoui R, Kamhieh-Milz S, Salama A. Differentially expressed microRNAs in maternal plasma for the non-invasive prenatal diagnosis of Down syndrome (trisomy 21). Biomed Res Int. 2014;2014:402475. 9 pages.